A Case of Cytokine Release Syndrome Induced by Avelumab and Axitinib Combination Therapy for Metastatic Renal Cell Carcinoma

Documenti analoghi

• Neoadjuvant Avelumab Plus Axitinib Enabling Curative Resection of Renal Cell Carcinoma With Direct Liver Invasion: A Case Report
  di: Fumihiro Ito, et al.
  Pubblicazione: (2026)
• Complete Response to Pembrolizumab After Progression on Avelumab Maintenance in Metastatic Urothelial Carcinoma
  di: Fumihiro Ito, et al.
  Pubblicazione: (2026)
• A Case of a Durable Partial Response to Late‐Line Axitinib Following Prior Use of Tyrosine Kinase Inhibitors in Metastatic Papillary Renal Cell Carcinoma
  di: Naoto Hodotsuka, et al.
  Pubblicazione: (2025)
• Long‐Term Response to Avelumab Maintenance Therapy and Durable Remission After Cessation in a Patient With Metastatic Urothelial Carcinoma of the Renal Pelvis: A Case Report
  di: Hiroyuki Fujinami, et al.
  Pubblicazione: (2025)
• Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis
  di: Shimpei Yamashita, et al.
  Pubblicazione: (2025)